MedTrace Logo

Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

NCT06876350 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-03-17

No results posted yet for this study

Summary

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Conditions

  • Carpometacarpal (CMC) Joint Arthritis

Interventions

OTHER

Woodcasting Splint

This is the experimental group so we could see the outcomes and preference for patients using surveys and compliance scores

OTHER

Control (Standard treatment)

Thermoplastic splints are standard of care treatment for patients after CMC arthroplasty. We will use the data from this group as the comparator to the experimental group.

Sponsors & Collaborators

  • Foundation for Orthopaedic Research and Education

    lead OTHER

Principal Investigators

  • Michael Doarn, MD · Florida Orthopaedic Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-03
Primary Completion
2025-05-31
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06876350 on ClinicalTrials.gov